SPL — Starpharma Holdings Income Statement
0.000.00%
Last trade - 00:00- AU$357.79m
- AU$347.48m
- AU$12.05m
Annual income statement for Starpharma Holdings, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 4.9 | 4.21 | 9.76 | 4.91 | 12.1 |
| Cost of Revenue | |||||
| Gross Profit | 2.12 | 3.09 | 9.12 | 3.69 | 11.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 21.3 | 20 | 17.9 | 15.8 | 20.1 |
| Operating Profit | -16.4 | -15.8 | -8.16 | -10.9 | -8.08 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -16.2 | -15.6 | -8.16 | -9.99 | -7.46 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -16.2 | -15.6 | -8.16 | -9.99 | -7.46 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -16.2 | -15.6 | -8.16 | -9.99 | -7.46 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -16.2 | -15.6 | -8.16 | -9.99 | -7.46 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.039 | -0.037 | -0.019 | -0.023 | -0.017 |